Search clinical trials for: BAY1905254

Total 1 results

Bayer
Merck Sharp & Dohme LLC

Active, not recruiting

Phase 1 Study of BAY1905254 - An Early Clinical Research Study to Evaluate a New Drug Called Bapotulimab (BAY1905254) in the Expansion Cohort in Combination With Pembrolizumab in Head and Neck Cancer That Has Returned or is Discovered to be Metastatic and is Expressing PDL1.

Advanced Solid Tumor | Head and Neck Squamous Cell Carcinoma

United States

3

Subscribe